| 3/4/2025 | CV | Market Commentary: Convertibles primary active with Alphatec, KKR offerings on deck; Sunrun takes a hit
|
| 2/26/2024 | CV | Market Commentary: Five9, Progress Software convertibles on deck; Super Micro Computer pulls back on hedge
|
| 2/23/2024 | CV | Market Commentary: New issues mixed; Super Micro convertibles gain; Sunrun ‘clobbered’; Lyft, Parsons up
|
| 2/23/2024 | CV | Market Commentary: Morning Commentary: Super Micro attracts bulk of secondary action; Sunrun ‘clobbered’
|
| 2/23/2024 | CVGN | New Issue: Sunrun sells $475 million 4% six-year convertibles at 99.75, up 27.5%
|
| 2/22/2024 | CV | Market Commentary: Super Micro, Sunrun, Lyft convertibles on deck; Parsons jumps; Rivian, Lucid pressured
|
| 2/22/2024 | CV | Market Commentary: Morning Commentary: Super Micro, Sunrun, Lyft convertible notes on deck; Parsons jumps
|
| 2/21/2024 | CV | Market Commentary: Floodgates open; Super Micro, Lyft, Sunrun, Parsons on tap; Global Payments jumps
|
| 2/21/2024 | CVGN | Sunrun talks $475 million six-year convertible notes to yield 3.5%-4%, up 27.5%-32.5%
|
| 3/13/2023 | CV | Convertible investors ‘cautious’ amid SVB fallout, liquidity concerns; opportunists eye market
|
| 10/29/2021 | CV | Market Commentary: Zendesk convertibles plunge in line with shares; Sunrun edges higher; primary quiet
|
| 10/20/2021 | CV | Market Commentary: Southwest Airlines in focus pre-earnings; Sea down outright; Sunrun trades; Avalara up
|
| 10/20/2021 | CV | Market Commentary: Morning Commentary: Sea, Sunrun convertible notes active in early secondary trading
|
| 1/28/2021 | CV | Sunrun greenshoe lifts 0% convertible notes due 2026 to $400 million
|
| 1/26/2021 | CV | Market Commentary: Marriott, Two Harbors on deck; BridgeBio, Sunrun in focus, trade up; Alarm.com active
|
| 1/26/2021 | CV | Market Commentary: Morning Commentary: BridgeBio, Sunrun convertible notes in focus, trade up on debut
|
| 1/26/2021 | CVGN | New Issue: Sunrun prices $350 million five-year convertible notes at 0%, up 50%
|
| 1/25/2021 | CV | Market Commentary: BridgeBio upsizes convertibles, tightens talk; Sunrun eyed; 21Vianet, Bentley soar
|
| 1/25/2021 | CV | Market Commentary: Morning Commentary: Planned BridgeBio Pharma, SunRun convertible offerings eyed
|
| 1/25/2021 | CVGN | Sunrun talks $350 million five-year convertibles to yield 0%-0.5%, up 42.5%-47.5%
|
